Salix Clears Teva's Ulcerative Colitis Drug For 2021 Launch
Salix Pharmaceuticals Inc. has struck a deal with Teva Pharmaceuticals USA Inc. to allow a generic version of its ulcerative colitis drug Apriso to come on the market in 2021, drawing...To view the full article, register now.
Already a subscriber? Click here to view full article